Correspondence 0001140361-23-046970 from Roivant Sciences Ltd. (ROIV) (CIK 0001635088) (ROIV)
Roivant Sciences Ltd. (ROIV) (CIK 0001635088)
Date: Oct. 4, 2023 · CIK: 0001635088 · Accession: 0001140361-23-046970
AI Filing Summary & Sentiment
File numbers found in text: 333-274804
Letter
ROIVANT SCIENCES LTD.
7th Floor
50 Broadway
London SW1H 0DB
United Kingdom
October 4, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E. Washington, D.C. 20549
Attn: Lauren S. Hamill
Re:
Roivant Sciences Ltd.
Registration Statement on Form S-3
File No. 333-274804
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Roivant Sciences Ltd., a Bermuda exempted limited company (the “Registrant”), hereby requests acceleration of effectiveness of its registration statement on Form S-3 (File No. 333-274804), as amended, to 4:00 p.m. Eastern Time on October 6, 2023, or as soon as practicable thereafter.
The Registrant hereby authorizes Derek J. Dostal and Stephen A. Byeff of Davis Polk & Wardwell LLP to orally modify or withdraw this request for acceleration.
Please contact Derek J. Dostal of Davis Polk & Wardwell LLP at (212) 450-4322 or derek.dostal@davispolk.com or Stephen A. Byeff of Davis Polk & Wardwell LLP at (212) 450-4715 or stephen.byeff@davispolk.com with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very truly yours,
ROIVANT SCIENCES LTD.
Show Raw Text
CORRESP
1
filename1.htm
ROIVANT SCIENCES LTD.
7th Floor
50 Broadway
London SW1H 0DB
United Kingdom
October 4, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E. Washington, D.C. 20549
Attn: Lauren S. Hamill
Re:
Roivant Sciences Ltd.
Registration Statement on Form S-3
File No. 333-274804
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Roivant Sciences Ltd., a Bermuda exempted limited company (the “Registrant”), hereby requests acceleration of effectiveness of its registration statement
on Form S-3 (File No. 333-274804), as amended, to 4:00 p.m. Eastern Time on October 6, 2023, or as soon as practicable thereafter.
The Registrant hereby authorizes Derek J. Dostal and Stephen A. Byeff of Davis Polk & Wardwell LLP to orally modify or withdraw this request for acceleration.
Please contact Derek J. Dostal of Davis Polk & Wardwell LLP at (212) 450-4322 or derek.dostal@davispolk.com or Stephen A. Byeff of Davis Polk & Wardwell LLP at (212) 450-4715 or stephen.byeff@davispolk.com with
any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Very truly yours,
ROIVANT SCIENCES LTD.
By:
/s/ Matt Maisak
Matt Maisak
Authorized Signatory